Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Onkure Therapeutics Inc OKUR

Healthcare Biotechnology
OnKure Therapeutics, Inc., formerly Reneo Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company focused on the discovery and development of precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. Using a structure-based drug design platform, the Company is building a robust pipeline of tumor-agnostic candidates. The... see more

Recent & Breaking News (NDAQ:OKUR)

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

Business Wire May 14, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHM

PR Newswire May 13, 2024

Lifshitz Law PLLC Announces Investigations of RPHM, SQSP, AGS, and LSAK

Accesswire May 13, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Reneo Pharmaceuticals, Inc. Merger

Newsfile May 13, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, RPHM

PR Newswire May 13, 2024

Shareholder Alert: Ademi LLP investigates whether Reneo Pharmaceuticals, Inc. has obtained a Fair Price in its Transaction with OnKure

PR Newswire May 13, 2024

RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders

Business Wire May 13, 2024

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

GlobeNewswire May 13, 2024

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

GlobeNewswire May 7, 2024

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

GlobeNewswire March 28, 2024

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors

GlobeNewswire March 25, 2024

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

GlobeNewswire December 14, 2023

Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results

GlobeNewswire November 13, 2023

Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire November 2, 2023

Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings

GlobeNewswire October 25, 2023

Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)

GlobeNewswire October 9, 2023

Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit

GlobeNewswire October 6, 2023

Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire August 29, 2023

Reneo Pharmaceuticals Reports Second Quarter 2023 Financial Results

GlobeNewswire August 10, 2023

Reneo Pharmaceuticals to Participate in SVB Securities Therapeutics Forum

GlobeNewswire June 30, 2023